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Abstract 
This paper assesses the efficiency of utilizing nurses in Washington State hospital pharmacies. We take the perspective 
of a pharmacy department manager and model an input oriented hospital pharmacy production process. Data 
envelopment analysis (DEA) is used to examine both scale efficiency and technical efficiency, and differences across 
hospital pharmacies that use and do not use nurse staffing are analyzed using cross-tabulations and nonparametric 
hypothesis tests. The results indicate that the use of nurse staffing does not significantly impact either scale or 
technical efficiency. Thus, permitting nurses to play a greater role in hospital pharmacies does not adversely affect 
efficiency. This paper has important policy implications for hospital administrators and pharmacists.
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Hospitals in the U.S. are facing a growing challenge in providing pharmaceutical 
services, especially in medically underserved areas (Pickette, Sodorff and Lordan 
2002; Traynor, Sorensen and Larson 2007).  Some see increased utilization of nurses 
in hospital pharmacies as a solution.  One example is pharmacy-based telemedicine 
(or “telepharmacy”), where nurses and pharmacy technicians use audio-visual 
technology to collaborate with pharmacists and other specialized practitioners at 
distant locations to provide pharmaceutical care (Peterson and Anderson, Jr., 2004; 
Friesner and Scott 2009).   
   Many hospital pharmacies employ nurses, either as relief for pharmacy 
technicians or, for specific tasks, as relief for registered pharmacists (Facchinetti, 
Campbell and Jones 1999).  In addition to relief work, the nursing staff may also 
collaborate with pharmacists on medication therapy and disease state management 
activities for chronic illnesses such as diabetes, hypertension and asthma (Leal and 
Soto 2005).  Further, many hospitals integrate pharmacy services into other cost 
centers or departments to ensure higher quality care.  For example, many emergency 
rooms and trauma centers now contain automated dispensing machines with a 
limited number of frequently used medications in standardized dosages. (Kester, 
Baxter and Freudenthal 2006).  While it is ultimately the pharmacy department’s 
responsibility to monitor and maintain both the machines and pharmaceutical care 
services provided, nurses working in these non-pharmacy departments may play a 
larger role in the provision of pharmaceutical care.   Given the potential 
opportunities for nurses to work in hospital pharmacies, it is interesting to examine 
whether hospitals that employ nursing staff in their pharmacies are more or less 
efficient than those that do not use nurses in this fashion.   
The debate surrounding the use of nurses in hospital pharmacies can be 
categorized along two lines: quality and efficiency.  Empirical evidence surrounding 
quality is sparse but does exist (Pickette, Sodorff and Lordan 2002; Casey et al. 
2008) and a few studies focus specifically on the efficiency of hospital pharmacies 
(Capettini and Morey 1985; Okunade 1993; Okunade 2001; Schumock et al. 2009).  
We expand this literature by examining the efficiency implications of using nurses to 
perform tasks traditionally performed by pharmacists.    The literature surrounding 
efficiency in the pharmacy has received scant attention, with only Schumock et al. 
(2009), Okunake (1993, 2001) and Capettini and Morey (1985) focusing on the 
hospital pharmacy as the unit of observation.  None of these studies give primary 
emphasis to the role that nurses play in the efficient provision of pharmacy services.  
Given the extensive use of pharmaceutical care in hospitals, the legal restrictions on 
pharmacy production, and the large variation in how pharmacies are staffed, the 
efficiency of hospital pharmacy units and the role that nurses play in this process 
deserves additional scrutiny. 
We present an exploratory, empirical investigation of the efficiency of 
utilizing nurses in Washington State hospital pharmacies.  We model an input 
oriented hospital pharmacy production process, and use a linear programming 
technique, data envelopment analysis (DEA), to examine both scale efficiency and 
technical efficiency differences between hospital pharmacies that staff nurses and 




results.  We conclude with policy implications arising from the analysis, as well as 
some suggestions for future work in this area.   
 
2. A Simple Model of Efficient Hospital Pharmacy Production 
Our analysis takes the perspective of the pharmacy department manager who 
must provide pharmaceutical care to all patients admitted to the hospital using the 
available resources allocated to the pharmacy department in the budgeting process.  
Since the pharmacy manager does not control the number and sickness of the 
patients admitted to the hospital, and by extension does not control the quantity of 
pharmacy services provided by his/her staff, the pharmacy manager is faced with an 
input-oriented production process (Capettini and Morey 1985; Okunade 1993). 
Rather than attempting to measure pharmacy department output with an 
intermediate measure, such as the number of prescriptions, consultations by the 
department staff or similar measures, (Fare et al. 1992; Fare, Grosskopf and Roos 
1995) we define output as the dollar value of the pharmacy department’s output as a 
proportion of the dollar value of output produced by the hospital.  We empirically 
characterize output using total inpatient pharmacy (billed) charges divided by total 
hospital inpatient charges as one measure, and total outpatient pharmacy charges 
divided by total outpatient charges for the hospital as a second output measure
1.  We 
do this for several, related reasons.  Using a simple measure of pharmacy output like 
the number of prescriptions filled may miss some significant parts of actual 
pharmacy practice.  Pharmacists in hospitals do much more than just fill 
prescriptions.  They visit with patients and consult with physicians, nurses, and 
dietary staff, among other tasks. These unmeasured but time-draining activities may 
be better caught by our measures than the number of prescriptions filled, especially 
since the latter may differ remarkably in complexity and ancillary pharmacy tasks.  
Also, in our dataset, a hospital pharmacy is not required to report the quantity of 
dispensing activity
2, nor does it report actual reimbursements at the departmental 
level.  More importantly, pharmaceutical care services are an intermediate output in 
a much more complex production process where pharmacy services are used to 
restore a patient’s health stock.  Patients with more severe illnesses will also likely 
require more intensive pharmaceutical care (in addition to other services) that may 
not be reflected in a metric such as the number of medications dispensed.  As an 
example, more severe illnesses may require medications that must be compounded or 
provided via infusion, and thus may take more time, energy and resources than less 
sick patients requiring standard medications that can be administered orally.  It is 
reasonable to assume that those more intensive services result in higher billed 
charges.  Measuring these charges separately for inpatient and outpatient care, and 
                                                           
1 We also note in passing that we used the total (real) dollar value of outpatient and inpatient 
pharmacy charges (not normalized by inpatient or outpatient hospital charges) as outputs and obtained 
qualitatively similar results.   
2 On the other hand, community (also known as retail) pharmacies are much more focused on 
dispensing activities, rather than clinical services.  As such, it is more appropriate to measure output 
in community pharmacies with variables such as prescription volumes (Fare et al. 1992; Fare, 




expressing each as a proportion of hospital charges, allows for a more detailed 
characterization of pharmacy services (measured in non-monetary units) both across 
the types of pharmacy services and in relation to the hospital as a whole. It also 
reflects the assumption that pharmacy services are an integral part of the overall care 
given patients. 
We assume that the manager uses several inputs to produce pharmaceutical 
care.  The manager has pharmacy staff (as measured by full time equivalent 
employees, or FTEs), which contains registered pharmacists, pharmacy assistants 
and possibly non-pharmacy staff, including nurses. Legal requirements also 
necessitate that the ratio of registered pharmacists to non-pharmacists working in a 
pharmacy does not fall below a pre-specified value.  We assume this ratio is not 
binding.  As will be discussed in section 4 of the manuscript (see footnote 4), the 
data used in this study are consistent with this assumption.   
Capital (inclusive of physical space and major equipment) is another input.  
A third input is the quantity of supplies, primarily medications, used by the 
pharmacy.  We account for differences in patient illness severity using a hospital-
wide casemix index.  Similarly, the size of the hospital also influences its resource 
constraints, and by extension the number and complexity of services offered.   
Theoretically, the measurement of technical efficiency in an input-oriented 
production processes is modeled through the use of isoquants, as illustrated in Figure 
1.  For simplicity, we assume that there are only two inputs (FTEs and capital) used 
to produce a fixed amount of output.  An efficient manager chooses input usage such 
that it lies on the isoquant, for example, at point X.  An inefficient manager utilizes 
too many inputs to produce the fixed output, and thus lies at a point above the 
frontier (for example, point Y in Figure 1).  In relative terms, inefficiency can be 
characterized by using a “distance function”, which measures the radial distance 
from the origin, through the efficient frontier, to the actual point of production (Fare 
and Primont 1995; Coelli, Rao and Battese 1998; Cooper, Seiford and Tone 2007).  
In the case of Figure 1, a pharmacy operating at point Y would have a distance 
function equal to the ratio 0X/0Y.  This measure is bounded between zero and one, 
with values of one implying full efficiency; that is, 0Y = 0X, which can only occur if 
the firm is on the isoquant such that X and Y are identical.  Efficiency can also be 
characterized in terms of physical units by using the reduction in inputs necessary to 
lie on the isoquant.  For the pharmacy in Figure 1, this amount is equal to the 
difference between the line segments 0FTEY and 0FTEX.  Further, the two measures 
are related; one could also characterize the distance function with the ratio 0FTEX / 
0FTEY. 
In general, an input-oriented production process assumes that a manager 
controls all of the inputs at her/his disposal, and takes as given the outputs the 
department must produce.  That is, all inputs are deemed “discretionary” (Banker 
and Morey 1986; Scheel 2000).  Within the context of the hospital pharmacy, this is 
slightly problematic because in addition to not being able to control outputs, the 
pharmacy manager also has little control over some of the inputs (i.e., those inputs 
are “non-discretionary”).  A manager has control over the number of FTEs utilized in 
the department, as well as the department’s medication supply.  In the long run, 




department, but likely do not control this variable in short run or intermediate time 
frames.  Hospital-wide variables, including the number of available beds and the 
casemix index, are also non-discretionary and may be used in the pharmacy at 
inefficient levels, as higher levels of hospital administration trade-off inefficiency in 
one cost center for efficiency in another.  Any empirical efficiency analysis across 
hospital pharmacies must take these considerations into account. 
In the event that a manager of an input-oriented production process is faced 
with non-discretionary inputs, one must alter how efficiency is characterized (Banker 
and Morey 1986; Scheel 2000).  For example, suppose that the manager depicted in 
Figure 1 cannot control capital, making this variable non-discretionary.  In such 
cases, the point X is not a realistic benchmark to measure efficiency, since the firm 
cannot change (reduce) the amount of capital in order to move to point X.  Instead, 
the appropriate benchmark is point W, where utilization of labor is reduced to the 
point where the pharmacy is on the isoquant, but capital is unchanged.  In this case, 
the distance function is characterized by the ratio 0FTEW / 0FTEY.  Note that 
efficiency will always be greater when an input is discretionary, because it allows for 
an efficient reference point that is closer in Euclidean distance to the actual point of 
production. 
 
3. Empirical Methodology 
  We investigate whether hospital pharmacies that employ nurses are more or 
less efficient than those that do not.  Because we have sparse prior literature and no a 
priori expectations to guide this determination, we choose the following null 
hypothesis: 
H0: There is no relationship between the use of nurses in a typical hospital pharmacy 
and whether that pharmacy is efficient or inefficient.     
In a discrete sense, the null hypothesis can be examined in a straightforward 
manner (Friesner, Rosenman and McPherson 2008; Friesner and Rosenman 2009).  
More specifically, one can generate cross-tabulations disaggregating whether a 
pharmacy is efficient or inefficient by whether or not it employs nurses in the 
pharmacy.  Under the null hypothesis hospital efficiency should be independent of 
nurse staffing.  The data are drawn from a random sample and a simple, standard chi-
square test of independence (or, in the event of low expected cell counts, Fisher’s 
exact test) can be applied to determine whether the hypothesis is rejected.  In all 
applications of the test, we advocate using a 5 percent significance level.   
  Two techniques are used to calculate efficiency scores, and each approach 
has positive and negative attributes (Coelli and Battese 1998; Jacobs 2001; 
Hollingsworth 2003).  Stochastic frontier analysis (SFA) is a regression-based 
approach that uses the regression’s covariates to empirically characterize the 
technology.  The efficiency estimates are subsequently decomposed from the 
model’s error term.  SFA is appropriate when the data are randomly drawn from the 
population, and when the researcher can reliably make a priori expectations about 
both the production technology and the distribution of efficiency scores vis-à-vis the 
regression’s error term.  It does not work well when these assumptions are violated.   
  The alternative, data envelopment analysis (DEA), is a linear programming 




the resulting efficiency estimates.  DEA is more appropriately applied when little is 
known about the production technology.  It is also robust to endogeneity 
considerations (which may be problematic for input oriented technologies) and can 
be used with random or convenience samples.   
There are two primary drawbacks to DEA.  The procedure is based on a 
linear programming algorithm, and therefore lacks well-defined statistical properties 
(Banker 1993; Simar and Wilson 2007; Kneip, Simar and Wilson 2009).  Moreover, 
studies indicate that the efficiency scores are not easily amenable to secondary 
regression analysis to determine which factors increase or decrease efficiency.
3  
Second, when applying DEA to convenience or randomly collected samples, the 
results may be severely distorted by outliers or out-of-sample information (Simar and 
Wilson 2007).  In these cases, DEA-based efficiency scores are biased upwards, and 
overstate efficiency.  Therefore, even if the data come from a randomly collected 
sample, it is difficult (and if one has a small sample or few covariates, impossible) to 
make meaningful statistical inferences using parametric or semi-parametric 
techniques (Banker 1993).  Consequently, for data drawn as a random sample, mean 
or median differences across a small number of exogenous factors may be analyzed 
using non-parametric (rank-order) hypothesis tests (Clement et al. 2008; Friesner, 
Rosenman and McPherson 2008; Friesner and Rosenman 2009).  For other types of 
data sets, a conservative approach is to place observations into discrete classes and 
examine differences across groups of efficiency metrics. 
  We use DEA for several reasons.  First, the data have multiple outputs, and 
thus are more amenable to DEA.  Second, the null hypothesis is, by definition, 
relative in nature; we examine whether hospitals using nurses are more or less 
efficient than those that do not. Consequently, the upward bias in DEA scores is not 
of substantial concern because we are interested in relative differences in efficiency 
across the two types of pharmacies.  The relative manner in which DEA constructs 
the efficient frontier is highly consistent with our relative hypothesis.  Also, we face 
data limitations on the number and types of covariates to explain efficiency 
differences across pharmacies, which would likely create omitted variable bias using 
SFA.  When applicable, we use rank-order nonparametric tests; hence the 
autocorrelation in DEA scores is not a significant concern.   
A final issue concerns the use of discretionary and non-discretionary inputs.  
Since this analysis is conducted from the perspective of the pharmacy department 
manager, it is likely that the manager can control the number of pharmacy FTEs, 
making this variable discretionary.  Supplies (i.e. medications) are also treated as 
discretionary.  However, the pharmacy department’s capital, as well as the hospital-
wide variables, including size and patient case-mix, are likely non-discretionary.  To 
account for these issues, we use Banker and Morey’s (1986) formulation of the 
input-oriented DEA linear program (LP), and refer the reader to that citation for the 
formal linear program.  All DEA calculations are conducted using the EMS program 
(Scheel 2000).  Subsequent analyses of all DEA results are conducted using SPSS, 
Version 16.0 (SPSS 2008).     
                                                           
3 The efficiency scores are highly serially correlated in an unknown manner (Simar and Wilson 2007) 
that makes it impossible to correct.  Thus, any estimates in the secondary regression would be biased, 






Our data come from Washington State hospitals for the years 2005 - 2007.  
Each year, the Washington State Department of Health requires each hospital in the 
State to report detailed financial and operating information.  This information is 
made publicly available on the Department’s website 
(http://www.doh.wa.gov/EHSPHL/hospdata/YearEnd/Default.htm).  The data are 
reported both at an aggregate level and, to the extent possible, at the level of the cost 
center or department.  Information on the number of full-time equivalent employees 
(including a binary indicator of whether nurses are included in the pharmacy 
department’s FTEs), and the square footage of the pharmacy cost center (which we 
use as a proxy for capital) are culled.  Supply utilization is measured by calculating 
the proportion of the pharmacy’s total expenses that are allocated to supplies.  We 
use two measure of pharmacy output: total inpatient pharmacy (billed) charges 
divided by total hospital inpatient charges; and total outpatient pharmacy charges 
divided by total outpatient charges for the hospital as a second output measure.  To 
control for the number and mix of services provided by the hospital as a whole 
(which necessarily impacts pharmacy department utilization), the total number of 
available hospital beds is included.  We assume that a larger number of beds 
indicates greater physical, technological and human resources, which in turn 
suggests the potential to provide a wider and more advanced set of services.  Patient 
illness severity is measured using a hospital wide casemix index generated by the 
Washington State Department of Health. 
The initial sample contains 97 hospitals and 291 observations.
4 A potentially 
confounding issue in the analysis is the nature of the hospital being examined.  For 
example, hospitals in rural areas may have difficulty recruiting pharmacists and 
technicians to work in the pharmacy, and thus be forced out of necessity to use nurse 
staffing in the pharmacy.  On the other hand, urban hospitals (which also tend to be 
larger) may be better able to incorporate nurses into the pharmacy production 
process via the use of technology: for example, placing an automated dispensing 
machine in an emergency room or trauma department.  As a result, we choose to 
limit our analysis to two specific groups of pharmacies that are of great public policy 
concern, are likely to use similar production technologies, produce similar services, 
and provide similar levels of health care quality: pharmacies housed in rural, non-
specialty, community-owned hospitals with less than 125 beds; and pharmacies 
located in urban, non-specialty, private, not-for-profit hospitals with more than 125 
beds.  We also eliminated those pharmacies which allocate no square footage to the 
pharmacy cost center, which allocate 0.0 FTEs to the pharmacy cost center, and 
which fail to report any productive activity at the level of the hospital.   Finally, all 
remaining hospitals except one provide both inpatient and outpatient pharmacy 
services.  We eliminate this observation to ensure consistency across our data.  We 
are left with two panels: 20 rural, general, community-owned hospital pharmacies 
                                                           




with 56 observations; and 25 urban, private, not-for-profit hospitals pharmacies with 
74 observations.  We apply DEA and test our hypotheses separately for each of these 
panels.  
Table 1 contains the names, definitions and some basic descriptive statistics 
for each variable.  Panel A contains information pertaining to rural, general, 
community-owned hospital pharmacies.  The hospitals housing these pharmacies 
have, at the mean (median), 34.46 (29) available beds per facility, and casemix 
indices of 0.69 (0.69).  The pharmacies located in these hospitals exhibit mean 
(median) FTEs of 4.05 (2.95) and a standard deviation of 3.61.  Approximately 
fourteen percent of these hospital pharmacy FTEs are nurses.   The mean (median) 
square footage of these pharmacies is 690.55 (720), with a standard deviation of 
529.82.  Sixty-two percent of the pharmacy’s expenses were generated by supplies. 
Lastly, the pharmacy generates, at the mean (median) 6.7 (6.2) percent of all 
outpatient billed hospital charges and 11.5 (11.5) percent of all inpatient billed 
charges.   
Table 1, Panel B contains information for urban, non-specialty, private, not-
for-profit hospitals.    The hospitals housing these pharmacies are much larger in the 
number and extent of services offered.  At the mean (median), these hospitals have 
269.05 (242) available beds per facility, and casemix indices of 1.04 (1.03).  The 
pharmacies located in these hospitals have mean (median) FTEs of 49.30 (41.30) and 
a standard deviation of 28.83.  Approximately twenty-six percent of these hospital 
pharmacy FTEs are nurses.   The mean (median) square footage of these pharmacies 
is also much larger, at 5,622.34 (4,503), with a standard deviation of 3,467.32.  In 
addition, 70.2 (68.0) percent of the pharmacy’s expenses were generated by supplies. 
Lastly, the pharmacy generates, at the mean (median) 7.8 (7.5) percent of all 
outpatient billed hospital charges and 12.1 (12.2) percent of all inpatient billed 
charges.   
More generally, our dataset is defined by information hospitals make 
available.  For example, our dataset is unique in that total FTEs and nursing FTEs in 
the pharmacy cost center are reported.  There is, however, no disaggregation between 
non-nursing FTEs, which for the most part are pharmacists and technicians.  This is 
of little consequence since the vast majority of non-nursing hospital pharmacy staff 
are, in fact, registered pharmacists.
5  Similarly, there are no quality or service 
intensity metrics available similar to those used in previous studies of primarily 
community pharmacy efficiency (Fare et al. 1992; Fare, Grosskopf and Roos 1995).  
To the extent possible, we control for these differences by narrowly defining the 
types of hospitals included in our analysis, as well as by carefully defining our output 
variables.  However, the lack of quality measures is certainly a limitation of our 
                                                           
5 In 2007, for example, 78 of the hospital pharmacies report information on FTEs and expenses (salary 
and benefit) per FTE.  These hospitals, on average, employee 23 FTEs, and the mean expense per 
FTE is $93,684.  Given that pharmacists and nurses earn substantially higher salaries than do 
pharmacy technicians (or interns), this implies that the non-nursing staff are primarily pharmacists 
(Desselle 2005; Scott and Halvorson 2007).  As mentioned earlier, this also implies that the ratio of 




analysis, and future research is necessary to examine how the inclusion of such 
metrics affect our findings.   
 
5. Results 
  Table 2 contains an analysis of technical efficiency for rural, non-specialty, 
community-owned hospital pharmacies.  Panel A contains efficiency scores.  This 
category of hospitals has a mean (median) level of technical efficiency equal to 
0.849 (0.933), implying that most pharmacies are closer to being fully efficient than 
fully inefficient.  The standard deviation of 0.171 corroborates this statement; most 
hospital pharmacies have efficiency scores between approximately 1.0 and 0.68.   
Table 2, Panel B contains the results from cross-tabulations disaggregating 
technical efficiency by nurse allocation for rural, non-specialty, community-owned 
hospital pharmacies.  Of the 56 hospital pharmacies in this category, 48 do not 
allocate nurses to the pharmacy and 8 allocate nurses.  Of the 48 hospital 
pharmacies, 20 are technically efficient and 28 are not.  Similarly, of the 8 
pharmacies that employ nurses, half are efficient (4) and half are inefficient.  Given 
the relatively even distribution of efficient and inefficient pharmacies that do and do 
not use nurse staffing, we conclude that allocating nurses to the pharmacy does not 
noticeably impact efficiency in these practice settings.  Thus, we fail to reject our 
null hypothesis.  The chi-square and Fisher’s exact tests corroborate these findings; 
none of the statistics and their corresponding probability values indicate rejection of 
the null at the 5 percent level.   
Technical efficiency results for urban, non-specialty, private not-for-profit 
hospital pharmacies are contained in Table 3, Panel A.    This category of hospitals 
has a median level of technical efficiency (0.828) which is slightly higher than the 
corresponding mean (0.840), implying that most pharmacies are closer to being fully 
technically efficient than fully technically inefficient.  A standard deviation of 0.135 
implies most firms have efficiency scores between approximately 0.98 and 0.71.   
Table 3, Panel B contains the results from cross-tabulations disaggregating 
technical efficiency by nurse allocation.  The results generally mimic those from 
Table 2.  Of the 74 hospital pharmacies in this category, 19 allocated nurses to the 
pharmacy and 55 did not.  Of these 55 pharmacies, 14 (or 25 percent) were 
technically efficient.  At the same time 5 of the 19 pharmacies that employ nurses (or 
26 percent) are technically efficient.  Once again, the chi-square and Fisher’s exact 
tests fail to find any significant association between technical efficiency and nurse 
allocation at the 5 percent level.  
 
6. Conclusions and Policy Implications 
  Our empirical analysis investigates whether hospital pharmacies that employ 
nurses are more or less efficient than those that do not.  Using two panels of annual 
data on Washington State, non-specialty hospitals (urban, private not-for-profit and 
rural, community-owned) over the period 2005-2007, we find that the use of nurses 
does not affect technical efficiency.   
  Our work has an important policy implication for hospital administrators and 
pharmacists.  Hospitals and other health systems often have difficulties recruiting 




pharmacy staff, one option is to allow nurses greater opportunities to collaborate 
with pharmacy staff in the provision of pharmaceutical care.  Since most nurses 
(especially those who do not have advanced clinical training) are trained as 
generalists, and are not well versed in the nuances of pharmacotherapy, this 
collaboration inevitably begs two questions: “Does allowing nurses a greater role in 
the pharmacy impact the quality of pharmacy services, including medication errors 
and patient safety?” and “Does allowing nurses to play a greater role impact the 
pharmacy’s efficiency?”  The first of these questions has been addressed in the 
literature, although the evidence is limited (Bond, Raehl and Franke 2002; Pickertte, 
Sodorff and Lordan 2002; Peterson and Anderson, Jr., 2004; Casey et al. 2008).  To 
the best of our knowledge, our paper is the first in the literature to address the latter 
of these issues, and the conclusion we draw is that there is not an adverse effect on 
efficiency.   
Our study has a number of limitations.  The data are not exhaustive, and we 
do not explore efficiency across all ownership and/or practice types; most notably we 
do not assess proprietary and specialty hospitals.  Additionally, the data come from a 
single U.S. state.  While regulatory and professional standards are relatively (but not 
perfectly) consistent across U.S. states
6, and thus suggest (but in no way proves) 
generalizability within the U.S., it is unclear whether our findings are generalizable 
to hospital pharmacies in other countries. Third, we do not fully account for positive 
(i.e., reduced medication interactions) or negative (i.e., medication errors) quality 
metrics commonly utilized in the provision of pharmaceutical care.  Fourth, we only 
assess two types of efficiency: technical efficiency and scale efficiency.  Thus it is 
also important to examine other efficiency-based metrics, most notably cost 
efficiency, congestion and dynamic productivity change, to fully explore this issue.  
Lastly, data limitations (including the small sample sizes and the use of convenience 
samples) and the empirical technique used to estimate efficiency (DEA) prevent us 
from using regression or other appropriate statistical techniques to undertake an 
extensive analysis of the determinants of efficiency.  Further work that examines 
hospital pharmacy efficiency while accounting for these factors would provide 
valuable information for pharmacy managers, hospital administrators and policy 
makers.                               
                                                           
6 A comparison of regulatory similarities and differences across U.S. states can be conducted by 
viewing information contained on the National Association of Boards of Pharmacy website 
(www.nabp.net).  This website contains links to each of the state board websites (which in turn 
contain state-specific regulations), as well as information on the national competency exam 
(NAPLEX).  It also contains links to several international pharmacy boards, including Canada, 







































Isoquant   Table 1: Variable Names, Definitions and Descriptive Statistics   
     
Panel A: Rural, Non-Specialty, Community-Owned Hospitals and Their Pharmacy Departments       
Variable  Description  Mean  Median  Deviation 
Fte  Number of full time equivalent employees allocated to the pharmacy  4.049  2.950  3.612 
Psupp  Proportion of total pharmacy operating expenses spent on supplies, primarily medications  0.620  0.617  0.154 
Avlbeds  Number of hospital-wide available beds  34.464  29.000  16.382 
Cmi  Hospital casemix index  0.690  0.689  0.103 
Sqfeet  Square footage of the pharmacy  690.554  720.000  529.820 
Pctiprev  Pharmacy's inpatient billed charges, divided by the hospital's inpatient billed charges  0.115  0.115  0.038 
Pctoprev  Pharmacy's outpatient billed charges, divided by the hospital's outpatient billed charges  0.067  0.062  0.030 
Nursedummy  Binary variable identifying whether nursing FTEs are allocated to the pharmacy  0.143  0.000  0.353 
Number of Observations  56     
Number of Firms    20     
         
Panel B: Urban, Non-Specialty, Private Not-for-Profit Hospitals and Their Pharmacy Departments       
Variable  Description  Mean  Median  Deviation 
Fte  Number of full time equivalent employees allocated to the pharmacy  49.296  41.295  28.832 
Psupp  Proportion of total pharmacy operating expenses spent on supplies, primarily medications  0.702  0.680  0.143 
Avlbeds  Number of hospital-wide available beds  269.054  242.000  128.334 
Cmi  Hospital casemix index  1.036  1.026  0.217 
Sqfeet  Square footage of the pharmacy  5622.338  4503.000  3647.316 
Pctiprev  Pharmacy's inpatient billed charges, divided by the hospital's inpatient billed charges  0.121  0.122  0.029 
Pctoprev  Pharmacy's outpatient billed charges, divided by the hospital's outpatient billed charges  0.078  0.075  0.039 
Nursedummy  Binary variable identifying whether nursing FTEs are allocated to the pharmacy  0.257  0.000  0.440 
Number of Observations  74     




Table 2: Efficiency Results for Rural, Non-Specialty, Community-Owned Hospital Pharmacies
Panel A: Efficiency Results for Rural, Non-Specialty, Community-Owned Pharmacies
Standard
Variable Description Mean Median Deviation
TE Input-oriented technical efficiency score 0.849 0.933 0.171
Panel B: Cross-Tabulations Disaggregating Technical Efficiency by Nurse Allocation to the Pharmacy
Do Not Allocate Nurses Allocate
to the Hospital Pharmacy Nurses Total
Not Technically
   Efficient 28 4 32
Technically
    Efficient 20 4 24









Table 3: Efficiency Results for Urban, Non-Specialty, Private Not-for-Profit Hospital Pharmacies
Panel A: Efficiency Results for Urban, Non-Specialty, Private Not-for-Profit Pharmacies
Standard
Variable Description Mean Median Deviation
TE Input-oriented technical efficiency score 0.840 0.828 0.135
Panel B: Cross-Tabulations Disaggregating Technical Efficiency by Nurse Allocation to the Pharmacy
Do Not Allocate Nurses Allocate
to the Hospital Pharmacy Nurses Total
Not Technically Efficient 41 14 55
Technically Efficient 14 5 19
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